Cargando…

Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study

PURPOSE: Neurofibromatosis 1 (NF1) is an autosomal dominant condition caused by pathogenic variants of the NF1 gene. A markedly increased risk of breast cancer is associated with NF1. We have determined the breast cancer survival and risk of contralateral breast cancer in NF1. METHODS: We included 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, D. Gareth R., Kallionpää, Roope A., Clementi, Maurizio, Trevisson, Eva, Mautner, Victor-Felix, Howell, Sacha J., Lewis, Lauren, Zehou, Ouidad, Peltonen, Sirkku, Brunello, Antonella, Harkness, Elaine F., Wolkenstein, Pierre, Peltonen, Juha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000349/ https://www.ncbi.nlm.nih.gov/pubmed/31495828 http://dx.doi.org/10.1038/s41436-019-0651-6

Ejemplares similares

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

A rare disease and education: Neurofibromatosis type 1 decreases educational attainment
por: Johansson, Edvard, et al.
Publicado: (2021)

Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST)
por: Ylä‐Outinen, Heli, et al.
Publicado: (2019)

Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors
por: Uusitalo, Elina, et al.
Publicado: (2017)

Increased risk for dementia in neurofibromatosis type 1
por: Kallionpää, Roope A., et al.
Publicado: (2021)

Neurofibromatosis type 1 of the child increases birth weight
por: Leppävirta, Jussi, et al.
Publicado: (2019)

Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study
por: Leppävirta, Jussi, et al.
Publicado: (2018)

Pediatric malignancies in neurofibromatosis type 1: A population‐based cohort study
por: Peltonen, Sirkku, et al.
Publicado: (2019)

Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage
por: Kurtelius, Arttu, et al.
Publicado: (2017)

Haploinsufficiency of the NF1 gene is associated with protection against diabetes
por: Kallionpää, Roope A, et al.
Publicado: (2021)

Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player
por: Pennanen, Paula, et al.
Publicado: (2021)

Craniofacial and oral alterations in patients with Neurofibromatosis 1
por: Visnapuu, Vivian, et al.
Publicado: (2018)

Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
por: Evans, D. Gareth, et al.
Publicado: (2018)

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
por: Zehou, Ouidad, et al.
Publicado: (2013)

Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)

Desmosomes in Developing Human Epidermis
por: Peltonen, Sirkku, et al.
Publicado: (2010)

Barriers of the peripheral nerve
por: Peltonen, Sirkku, et al.
Publicado: (2013)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis
por: Malminen, Maria, et al.
Publicado: (2002)

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
por: Carton, Charlotte, et al.
Publicado: (2023)

Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)

Tight junctions in Hailey-Hailey and Darier's diseases
por: Raiko, Laura, et al.
Publicado: (2009)

Keratinocyte Growth Factor Induces Gene Expression Signature Associated with Suppression of Malignant Phenotype of Cutaneous Squamous Carcinoma Cells
por: Toriseva, Mervi, et al.
Publicado: (2012)

Diversity of actin architecture in human osteoclasts: network of curved and branched actin supporting cell shape and intercellular micrometer-level tubes
por: Pennanen, Paula, et al.
Publicado: (2017)

The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
por: Basu, Narendra Nath, et al.
Publicado: (2021)

Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer
por: Pegington, Mary, et al.
Publicado: (2022)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

Extended gene panel testing in lobular breast cancer
por: van Veen, Elke M., et al.
Publicado: (2021)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Cancers cutanés et COVID-19 : quel impact des deux vagues du COVID-19 sur le télédiagnostic des cancers cutanés ?
por: Skayem, Charbel, et al.
Publicado: (2021)

Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
por: Evans, D.Gareth, et al.
Publicado: (2021)

Contralateral Breast Cancer With Multiple Primary Neoplasms in a Patient With Neurofibromatosis Type 1: A Case Report and Review of the Literature
por: Veettil, Shifaz M, et al.
Publicado: (2021)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

Neurofibromatosis I and multiple sclerosis
por: Bergqvist, Christina, et al.
Publicado: (2020)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Metaplastic Breast Cancer in a Patient with Neurofibromatosis
por: Chaudhry, Umar Shafique, et al.
Publicado: (2015)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rsimpigap3pea21jq6av24qpks